In all three of the p53-mutant tumors, the matching EpCAM−CD90++ cells were negative and therefore p53 wild-type, verifying that these were not cancer-derived cells that had lost EpCAM expression and/or gained a mesenchymal phenotype via epithelial-to-mesenchymal transition. The gene discussed is TP53; the disease is cancer.